Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Post by Biostocks01on Apr 03, 2011 2:26pm
453 Views
Post# 18379138

The futur is bright!!

The futur is bright!!The facts... 

1) We have seen the generation of consolidated positive EBIDTA for the fiscal year ending 2010 as well as the first year of positive net income in recent operating history for the Company.

2)PharmaForm has experienced significant increases in margins and we anticipate continued growth.

3)We believe our Fentanyl TAIFUN® product candidate is currently in a lead position and anticipate it will become the first approved inhaled fentanyl product.

4)We have two partners,Janssen Pharmaceuticals and Teikoku Seiyaku Co. Ltd.

5) We have only 32M shares getting a strong leverage.

6) Our share is underestimated in stock exchange and If we annualize our results of December 2010 of .03 excluding the unusual items, we obtain 0.12$. In 8 times the annual results, we obtain an evaluation of 0.96/share.

Yes we always have a problem of liquidity but with the good results of 2010, we shall obtain the confidence of financial markets.

The important volume of transactions of the last weeks, allow to believe an important event gets ready.

Good luck all!!

Bio

<< Previous
Bullboard Posts
Next >>